MetLife's stock (NYSE: MET) has gained roughly 12% YTD as compared to the 7% drop in the S&P500 index over the same period. Further, at its current price of $70 per share, it has an upside potential of 8% to its fair value of $76 – Trefis' estimate for MetLife's valuation. The insurance giant surpassed the consensus estimates in fourth-quarter results, with total revenues increasing 3% y-o-y to $20.1 billion.